Before reading this article, it is important to understand that Cord Blood Stem Cell Therapy is not a United States FDA approved procedure or therapy. New Hope Medical Center does not perform this alternative cancer treatment in the US. Stem cells are the original (primordial) cells produced in the human body, with the capability to differentiate along any line or into any type of cell (totipotent). They divide and multiply within the human body. The first stem cells originate within the developing embryo ( blastocyst). These embryonic stem cells have to ultimately create the entire human body.

Umbilical stem cells used for this alternative cancer treatment are harvested from the umbilical cord of a full term live birth, not from an aborted fetus. This type of stem cell therapy involves the introduction of healthy new stem cells into the body to repair and replace damaged or lost cells.

Many of the so-called “incurable diseases” can be caused by the degeneration of specific cell types in the body.

The use of stem cell medicine was first used in 1956 by Dr. E. Donnall Thomas, a bone marrow transplant specialist. He administered donor adult stem cells to a leukemia patient who went into complete remission.

Dr. Thomas and Joseph E. Murray are co-winners of the 1990 Nobel Prize in the Physiology of Medicine for their contribution on discoveries concerning cell and organ transplantation in the treatment of human diseases.

Cord blood stem cells have been used in the treatment of blood cancers and/or blood diseases since 1988.

In 1988, Elaine Gluckman replaced allogenic cord blood for a bone marrow transplant in order to treat Fanconi’s Anemia, a rare recessive blood disorder. The child remains completely disease free.

In 1998, at the University of Wisconsin, James Thompson isolated the first embryonic stem cells from a blastocyst of a five day old in vitro fertilized egg. This discovery started the scientific movement to do studies, documents, and many debates over the ethical issues surrounding embryo destruction for medical purposes.

In 2001 treatment protocols were developed which permitted the removal of white blood cells from the cord, making the treatment safe with no risk of Graft verse Host Disease. These protocols also proved there is no need for HLA matching when using the cells for alternative cancer treatment.

In 2002, Catherine Verfaillie at the University of Minnesota proved that CD34+ stem cells from bone marrow could repopulate every single cell in a developing mouse. This study started more studies using adult stem cells to generate far more than just blood cells. It became proven there are great potentials for adult stem cells to treat a wide range of blood diseases, cancers, degenerative diseases and injuries.

In 2002, studies were released which proved that adult stem cells have the power to rebuild or reconstruct every cell in the body, not just the blood cells, therefore proving to be a very valuable alternative cancer treatment.

In 2004, Duke University published data from a human study confirming the Verfaillie study. The study featured the heart treatment of a boy who received CD34+ stem cells derived from donated cord blood. Not only did the investigation show differentiation to neurons and other cell types, but also proved that cord blood stem cells:

Migrate to the site of disease

Had the ability to differentiate into specialized heart cells

Engraft yielding clinical benefits.

There are several types of Stem Cell Therapies: New Hope Medical Center only advocates the use of Umbilical Stem Cells derived from donated live full term births for use in alternative cancer treatments.

Whole Cord Blood Stem Cell Therapy- involves the use of stem cells derived from full term births which were donated with informed consent. It is customary that after the birth of a new born child, the hospital destroys the waste products such as the umbilical cord and placenta. When permission is given by the parents, research goes forward and the umbilical cord is sent to the laboratory to be tested for many diseases and the different stem cells are harvested. Unlike embryonic or fetal stem cells, cord stem cells are programmed to rapidly support the development and growth of all body systems, and are pluripotent—capable of differentiating into every single specialized body cell.

Purified and Potentiated Cord Blood Stem Cell Therapy- involves the use of proprietary protocols to remove the white and red blood cells from cord blood leaving only stem cells. This process negates the risk of Graft versus Host Disease and the need for cross matching. Post thaw viability is potentiated with special freeze media.

Embryonic Stem Cells Therapy- involves the use of cells extracted from a five day old in vitro fertilized embryo. The viability of this cell type is limited, because only small numbers of cells can be derived from an embryo, and thus, they need to be expanded in the lab, currently with an animal intermediary, which limits their use in humans. Also, these cell lines are limited for use by government.

Fetal Stem Cell Therapy- involves the use of human fetuses aborted between the first and third months. Retrieval of fetal stem cells in adequate numbers is limited.

Adult Stem Cell Therapy- involves the use of stem cells derived from bone marrow, peripheral blood, and some tissues. Adult stem cells are understood to be 1/1000 as powerful as cord stem cells, since they have endured age stresses, toxicity, and often, disease. Their use is limited by the risk of graft versus host disease, and finding HLA matched donors.

Distinguishing Factors for Our Affiliated Facility’s Use of Cord Stem Cells

* ETHICAL We use only human umbilical cords from full term births, with informed consent donations.

* SAFE Cord stem cells used are certified infectious disease free per safety standards of The American Association of Blood Banks, and are purified to minimize graft versus host disease. Donors are screened for congenital/hereditary disorders. Hepatitis B and C, HIV 1 and 2, HTLV, CMV, Syphilis, Fungal/ routine bacterial cultures, and /ABO/Rh testing is done.

* VIABILITY Cord stem cells used, have enhanced viability, because of a special freeze media used.

* ENHANCED POTENTIAL Cord stem cells used are selected for their potential to engraft and grow in correlated diseased tissues, and can be genetically enhanced for disease/ tissue/cell/gene specific dysfunctions.

* QUANTIFIED Cord stem cells used are assayed for specific type cell count per vial, and kept frozen with monitored liquid nitrogen storage.

The Following includes, but are not limited to a small list of conditions which have proven to be responsive to the alternative cancer treatment, Cord Blood Stem Cell Therapy.

The alternative cancer treatment, Cord Blood Stem Cell Therapy is not approved for use in the United States and is not FDA approved. New Hope Medical Center in no way presents this therapy as a cure for any medical condition. Information on this site should in no way be interpreted to represent a claim or guarantee for a cure or clinical benefit to any disease, illness or injury. This therapy is not performed by NHMC in the United States. If you are interested in Umbilical Cord Stem Cell Therapy as an alternative cancer treatment, you will be referred for one day to an affiliated physician’s facility in Mexico.